Update Series Volume 39 (2020)
New for 2020! Audio Lessons - Listen on-the-go!
Access audio recordings of all 40 lessons to conveniently stream the material on-the-go! Audio Lessons will be released in coordination with their online companion lessons.
Listen now and tell us what you think!
For the most timely topics and latest surgical techniques in urology, you won't want to miss the 2020 AUA Update Series—AUA's most popular self-study CME product.
- Concise, practical lessons on timely topics
- State-of-the-art surgical techniques
- Authors are among the best in their specialties
Earn up to 40 AMA PRA Category 1 Credits™
Now in its 39th installment, the AUA Update Series is renowned for delivering high-quality lessons to practicing urologists, fellows and residents. All content is developed in consultation with and edited by internationally recognized experts in urology, making the AUA Update Series the most professional and sought-after self-study program available. Improve your practice and patient care by staying abreast of the latest treatments and surgical techniques in urology.
Benefit from leading urologists’ recommendations in 40 new lessons, which are delivered to you five lessons a month for eight months. Take advantage of a convenient, easy-to-access educational product that fits your individual learning style.
Subscribers can obtain CME credit instantly! Simply complete the content-related, online posttests to receive immediate CME credit.
Hot Topics for 2020:
- Lymphadenectomy for Bladder, Prostate and Kidney Cancer
- Critique/Update on Testosterone Guidelines
- A Critical Appraisal of the Stress Urinary Incontinence Guidelines
- A Practical Approach for Bothersome Post-void Dribbling
- Impact of Obesity on Urological Surgery
- Pediatric Cancer Survivor: What a Urologist Needs to Know
- Imaging for Upper Urinary Tract Calculi: Adult and Pediatric
- Management of Penile Fracture
- The Evolving Treatment of Metastatic Hormone Sensitive Prostate Cancer
- Managing Complications from Urinary Diversion
If you like to answer questions to help you study and learn, we are continuing to offer Test Your Knowledge activities with each release of the Update Series.
Subscribers will be emailed each of the 8 scheduled release months when lessons become available. Lessons may be accessed through the AUAUniversity under My Activities tab and through the Quick Links tab.
Scheduled release months: January, March, April, June, August, September, November, and December
Subscription Rates
Membership Category | Online Only* | Print Upgrade** | Total with both Formats |
---|---|---|---|
Member | $310 | $70 | $380 |
Non-Member | $385 | $95 | $480 |
Allied Member | $185 | $45 | $230 |
Allied Non-Member | $230 | $45 | $275 |
Resident/Fellow Member Letter of verification may be required. | $70 | $45 | $115 |
Resident/Fellow Non-Member | $85 | $45 | $130 |
International Resident/Fellow Member | $70 | $310 | $380 |
International Resident/Fellow Non-Member | $85 | $395 | $480 |
*Includes Online Only format.
**Additional fee applies for the mailed Print copy. The mailed Printed copy is not sold separately. Shipping Fees: U.S. and Canada, add shipping fee of $6.95; International, add shipping fee of $45.00.
All Update Series content is available online. Due to the impact of COVID-19, the mailing of print versions could be delayed. Know that we will work to complete your order as soon as possible. We thank you for your patience and look forward to continuing to serve you.
Online access will not be affected and access will begin after payment for new subscribers.
The American Urological Association designates this enduring material for a maximum of 40 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Target Audience
- Urologists
- Board candidates
- Residents
Learning Objectives
After completing all 40 lessons, participants, will be able to apply their knowledge and competencies on the urologic topics covered in each article. Each of the 40 lessons has a specific objective specific to the related article.
Update Series Advisory Group
Name | Company | Role |
---|---|---|
Benjamin Newell Breyer, MD, FACS | World Journal Urology | Health Publishing |
Sexual Medicine Open Access | Health Publishing | |
Shelby Englert | Nothing to disclose | |
E. Ann Gormley, MD | ACGME | Leadership Position |
ABMS | Leadership Position | |
AUA Updates | Leadership Position | |
Cheryl Taylore Lee, MD | merck | Consultant or Advisor |
Mel Rite | Scientific Study or Trial | |
Brian Matlaga, MD, MPH | Boston Scientific | Consultant or Advisor |
David Christopher Miller, MD, MPH | Blue Cross Blue Shield of Michigan | Other |
National Cancer Institute | Scientific Study or Trial | |
John Patrick Mulhall, MD | Association of Peyronie's Disease Advocates (APDA) | Leadership Position |
sexual medicine society of north america | Leadership Position | |
the journal of sexual medicine | Leadership Position | |
vault | Consultant or Advisor | |
Curtis Nickel, MD | Farr Laboratories | Consultant or Advisor |
AUA | Health Publishing | |
NIH | Scientific Study or Trial | |
Canadian Institute of Health Research | Scientific Study or Trial | |
Alvio Therapeutics | Consultant or Advisor | |
Seikagaku Corporation | Consultant or Advisor | |
RedLeaf Medical | Scientific Study or Trial | |
TEVA | Consultant or Advisor | |
Craig Stuart Niederberger, MD | AMERICAN SOCIETY FOR REPRODUCTIVE MEDICINE | Leadership Position |
NexHand | Leadership Position | |
Ferring Pharmaceuticals | Scientific Study or Trial | |
Core outcomes measure for infertility trials (COMMIT) | Consultant or Advisor | |
Victor William Nitti, MD | Astellas | Health Publishing, |
Allergan | Health Publishing | |
Serenity Pharmeuticals | Investment Interest | |
Medtronic | Scientific Study or Trial | |
Amphora | Scientific Study or Trial | |
J. Kellogg Parsons, MD, MHS | MDx Health | Consultant or Advisor |
Dendron | Consultant or Advisor | |
Boston Scientific | Consultant or Advisor | |
Eila Curlee Skinner, MD | Genentech | Scientific Study or Trial |
Stacy T. Tanaka, MD | AUA Update Series | Health Publishing |
Journal of Urology | Health Publishing | |
Centers for Disease Control and Prevention (CDC) | Scientific Study or Trial | |
American Board of Urology | Other | |
American Academy of Pediatrics, Section on Urology | Leadership Position | |
J. Christian Winters, MD | StimGuard | Consultant or Advisor |
CME CREDITS EXPIRATION:
Please note: CME Credits expire after three years of original release date. Answers must be submitted by the CME credits expiration deadline to receive credit for that year. Refer to CME expiration table below:
CME Credits Expiration Date | |
---|---|
2020 Update Series | Month, 2023 |
2019 Update Series | Month, 2022 |
2018 Update Series | Month, 2021 |
2017 Update Series | Month, 2020 |
2016 and prior years | Not eligible for CME credits. |
This self-study continuing medical education activity is designed to provide urologists, Board candidates and/or residents affordable and convenient access to the most recent developments and techniques in urology.
ACCREDITATION:
The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
CREDIT DESIGNATION:
The American Urological Association designates this enduring material for a maximum of 40.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
OTHER LEARNERS:
The AUA is not accredited to offer credit to participants who are not MDs or DOs. However, the AUA will issue documentation of participation that states that the activity was certified for AMA PRA Category 1 Credit™.
EVIDENCE BASED CONTENT:
It is the policy of the AUA to ensure that the content contained in this CME enduring material activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.
AUA DISCLOSURE POLICY:
All persons in a position to control the content of an educational activity (i.e., activity planners, presenters, authors) participating in an educational activity provided by the AUA are required to disclose to the provider any relevant financial relationships with any commercial interest. The AUA must determine if the individual’s relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.
RESOLUTION OF IDENTIFIED CONFLICT OF INTEREST:
All disclosures will be reviewed by the program/course directors or editors for identification of conflicts of interest. Peer reviewers, working with the program directors and/or editors, will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:
- Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director, editor and/or Education Conflict of Interest Review Committee or its subgroup.
- Limit content to evidence with no recommendations
- Introduction of a debate format with an unbiased moderator (point-counterpoint)
- Inclusion of moderated panel discussion
- Publication of a parallel or rebuttal article for an article that is felt to be biased
- Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
- Divestiture of the relationship by faculty
OFF-LABEL OR UNAPPROVED USE OF DRUGS OR DEVICES:
It is the policy of the AUA to require the disclosure of all references to off-label or unapproved uses of drugs or devices prior to the presentation of educational content. The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.
DISCLAIMER:
The opinions and recommendations expressed by faculty, authors and other experts whose input is included in this program are their own and do not necessarily represent the viewpoint of the AUA.
REPRODUCTION PERMISSION:
Reproduction of written materials developed for this AUA activity is prohibited without the written permission from individual authors and the American Urological Association.
PEER REVIEW:
Peer review is the principle mechanism by which the quality of the AUA Update Series content is judged by the AUA Update Series Advisory Board.
Released date: Release month, 2020
Expiration date: Release month, 2023
Price
All Update Series content is available online. Due to the impact of COVID-19, the mailing of print versions could be delayed. Know that we will work to complete your order as soon as possible. We thank you for your patience and look forward to continuing to serve you.
Online access will not be affected and access will begin after payment for new subscribers.
All subscribers receive the Online format and will have the option to add the mailed Print format to their subscription during checkout.
Please log in to see your member rate and purchase.
Subscribers will be emailed each of the 8 scheduled release months when lessons become available. Lessons may be accessed through the AUAUniversity under My Activities tab and through the Quick Links tab.
Scheduled 2020 release months: January, March, April, June, August, September, November, and December